The year has gotten off to a warm start, though not quite red hot, when...
A-Lists
The idea of a “patent cliff” wave of exclusivity expirations shaking up the biopharma industry...
A July report by a team of Jefferies analysts paints an upbeat picture for contract...
Credit: Charles River Laboratories Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug...
Addressing analysts earlier this year, executives from Alexandria Real Estate Equities discussed some sobering trends...
Credit: Emris / iStock / Getty Images Plus As the largest purchaser of pharmaceuticals, Americans...
With apologies to Charles Dickens, the market for gene therapies can be summed up as...